Mayur Parmar

Neuroscientist - Study Alzheimer's & Parkinson’s disease
Assoc. Professor - Pharmacology @NSUFlorida
Academic journey - LIU, Duquesne, Weill Cornell, UF

[Mayur Parmar @parmar399]

Support our Walk to End Alzheimer's by registering for the walk and/or donating to our team, and help us fight to #ENDALZ. 💜

Register for the walk:
2026 Walk to End Alzheimer's - Pinellas County, FL
NSU KPCOM TBRC | Walk to End Alzheimer's
https://t.co/ptdkCVrLNm
@alzcnfl

[Alzheimer's Association, Southeast Florida @alzsefl]

On Sept. 9, join us for Broward County Caregivers' Day, a free hands-on dementia caregiver training with practical tools, expert guidance and real support. The event was coordinated with Dr. Erik Ilyayev, an Alzheimer's Association board member, and is hosted and sponsored by Forest Trace Senior Living.

Samrah Mitha, MPH, of the Alzheimer's Association will join as one of the guest speakers, along with Dr. Ilyayev and other others.

📍 Forest Trace Senior Living
🕙 10 a.m.-1 p.m.
Space is limited to 100 attendees.

Learn more and register free at https://t.co/9r2Ogtue11.

[Mayur Parmar @parmar399]

We're proud to support the Walk to End Alzheimer's® and the fight against Alzheimer's and other dementias. Every donation helps advance research, support caregivers, and bring hope to families. Please contribute💜💜 #ENDALZ

NSU-Team: https://t.co/ptdkCVrLNm

@alzassociation

[Dr Helix @peptidescafe]

Researchers are exploring semaglutide's potential neuroprotective effects for neurological & neurodegenerative disorders. Early studies suggest fascinating mechanisms. Discover more on this FDA-approved peptide's journey! https://t.co/ojAhu2kBfC #peptidesr…

[Mayur Parmar @parmar399]

🎉 Excited to share our latest review article, “Gene therapy for Parkinson’s disease: current landscape, translational challenges, and future directions,” published in Expert Review of Neurotherapeutics #GeneTherapy #ParkinsonsDisease #Neurotherapeutics

https://t.co/EAMkDRHKZA

[Springer Medicine Journals @ClinMedJournals]

Celiac disease is more than an autoimmune enteropathy. This review in #SNCCM explores the hidden economic, psychological, and societal CD costs, emphasising the role of diagnostic delays, comorbidities, work loss, and the true price of a gluten-free diet. https://t.co/bwyPvKRkPl

[Mayur Parmar @parmar399]

I am excited to share my research is now published! 📚
Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide
https://t.co/cZuSvAPwKd
#Semaglutide #Neuroinflammation
@SN

[Mayur Parmar @parmar399]

Excited to share my research highlights for 2025! Check out this personalised summary of my Springer Nature publications and the impact of my research in 2025.

https://t.co/0ISmOdulBV #SNAuthors #YiR2025

[Mayur Parmar @parmar399]

🧠 Bridging the gap in Alzheimer’s research: Resveratrol (RSV) shows promise, but clinical translation remains a challenge. This schematic highlights 3 key strategies to overcome RSV’s poor bioavailability & rapid metabolism - 📃🔗https://t.co/Y99gaYaINq

[Mayur Parmar @parmar399]

Balancing Caution and Exploration in Ivermectin’s Use for Cancer. Key principles for healthcare providers to manage patient inquiries, combat misinformation, and support evidence-based research.
https://t.co/5cU4qTq1m2

[Parkinson's Disease Center at BIDMC @BIDMC_PD_Center]

Prasinezumab (anti-alpha-synuclein antibody) is moving forward into a phase 3 clinical study to test the potential for slowing (delaying) progression of Parkinson's!
https://t.co/yGyIE2LPAH

[Mayur Parmar @parmar399]

https://t.co/dc7MMjMd1y

[Mayur Parmar @parmar399]

📢 New Development: Wegovy (Semaglutide), a GLP-1 agonist initially developed for type 2 diabetes.

🚨 FDA Approval: The U.S. FDA has approved Novo Nordisk’s weight-loss drug, Wegovy, for reducing ❤️ heart risks in overweight or obese adults without diabetes. #semaglutide

[Mayur Parmar @parmar399]

Note: Wegovy was first FDA-approved for obesity treatment in June 2021.

[Florida Osteopathic Medical Association @FloridaDOs]

This year, the FOMA Student Awards will be presented on February 17, 2024 at the FOMA Live Convention. This year, the winners from NSU-KPCOM Tampa Bay are:
- Matthew Green
- Jason Nguyen
Congratulations to our winners, we cannot wait to see what the future holds for you all! 🎉

[Mayur Parmar @parmar399]

We are thrilled to announce our latest publication on the newly approved drug called "Tofersen" for ALS. This open-access drug chapter will serve as an excellent resource for educating healthcare professionals about this innovative treatment option. #ALS #healthcare #education

[Mayur Parmar @parmar399]

@jjlcerillo @NSUResearch Working with you on the newly approved drug for ALS was a wonderful experience. Congratulations on your accomplishment.